Table 2 Diagnosis-Treatment Scores by CPV Variant

From: Randomized prospective trial to detect and distinguish between medication nonadherence, drug-drug interactions, and disease progression in chronic cardiometabolic disease

Medication Nonadherence
Study arm	R1	R2	p-value
Control	21.2%±12.1%	24.0%±14.6%	0.195
Intervention 1	25.0%±13.2%	38.2%±22.1%	< 0.001
Intervention 2	25.3%±14.4%	30.4%±20.0%	0.031
p-value	0.102	< 0.001
Drug-drug Interaction
Study arm	R1	R2	p-value
Control	16.1%±13.6%	18.8%±13.7%	0.216
Intervention 1	17.4%±15.1%	31.0%±18.4%	< 0.001
Intervention 2	19.4%±13.7%	19.7%±17.9%	0.449
p-value	0.331	< 0.001
Disease Progression
	R1	R2	p-value
Control	20.8%±10.9%	23.6%±10.9%	0.140
Intervention 1	24.9%±12.0%	20.1%±10.3%	0.004
Intervention 2	24.6%±11.4%	21.5%±10.3%	0.036
p-value	0.055	0.124

Back to article page